BR0108958A - Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina - Google Patents

Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina

Info

Publication number
BR0108958A
BR0108958A BR0108958-7A BR0108958A BR0108958A BR 0108958 A BR0108958 A BR 0108958A BR 0108958 A BR0108958 A BR 0108958A BR 0108958 A BR0108958 A BR 0108958A
Authority
BR
Brazil
Prior art keywords
ciprofloxacin
controlled release
release system
orally administered
daily administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0108958-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Naresh Talwar
Ashok Rampal
John N Staniforth
Gour Mukherji
Brij Khera
Badri N Vishwanathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of BR0108958A publication Critical patent/BR0108958A/pt
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0108958-7A 2000-03-03 2001-02-28 Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina Withdrawn BR0108958A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
BR0108958A true BR0108958A (pt) 2003-09-30

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108958-7A Withdrawn BR0108958A (pt) 2000-03-03 2001-02-28 Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina

Country Status (31)

Country Link
EP (1) EP1263409A1 (es)
JP (1) JP2003525229A (es)
KR (1) KR20030009374A (es)
CN (1) CN1420763A (es)
AP (2) AP1485A (es)
AR (1) AR032614A1 (es)
AU (1) AU3589701A (es)
BG (1) BG107055A (es)
BR (1) BR0108958A (es)
CA (1) CA2400950A1 (es)
CZ (1) CZ20022883A3 (es)
DO (1) DOP2001000130A (es)
EA (1) EA200200914A1 (es)
EC (1) ECSP013952A (es)
EE (1) EE200200497A (es)
GT (1) GT200100033A (es)
HN (1) HN2001000038A (es)
HR (1) HRP20020715A2 (es)
HU (1) HUP0204417A3 (es)
IL (1) IL151553A0 (es)
IS (1) IS6532A (es)
MX (1) MXPA02008568A (es)
NO (1) NO20024108L (es)
NZ (1) NZ520927A (es)
OA (1) OA12381A (es)
PE (1) PE20011113A1 (es)
PL (1) PL365071A1 (es)
SK (1) SK12542002A3 (es)
WO (1) WO2001064183A1 (es)
YU (1) YU66202A (es)
ZA (1) ZA200206764B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
WO2017143438A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EE200100153A (et) * 1998-09-14 2002-06-17 Ranbaxy Laboratories Limited Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
PL365071A1 (en) 2004-12-27
YU66202A (sh) 2005-09-19
KR20030009374A (ko) 2003-01-29
NO20024108L (no) 2002-10-25
ZA200206764B (en) 2003-03-04
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
CA2400950A1 (en) 2001-09-07
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
HUP0204417A3 (en) 2005-03-29
CZ20022883A3 (cs) 2003-04-16
CN1420763A (zh) 2003-05-28
AP1485A (en) 2005-10-31
IS6532A (is) 2002-08-28
AP2002002627A0 (en) 2002-09-30
BG107055A (bg) 2003-06-30
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
HN2001000038A (es) 2005-03-23
IL151553A0 (en) 2003-04-10
OA12381A (en) 2004-09-06
AR032614A1 (es) 2003-11-19
PE20011113A1 (es) 2001-10-14
NO20024108D0 (no) 2002-08-28
SK12542002A3 (sk) 2003-05-02
HRP20020715A2 (en) 2004-12-31
DOP2001000130A (es) 2004-03-31
NZ520927A (en) 2003-06-30
EA200200914A1 (ru) 2003-02-27
WO2001064183A1 (en) 2001-09-07
EE200200497A (et) 2004-02-16
AU3589701A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
BRPI0414907A (pt) formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
BR9916224A (pt) Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
BRPI0408999A (pt) comprimidos prensados de multiparticulados de liberação oral prolongada
BR0108958A (pt) Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina
BR9901782A (pt) Forma para dosagem de nefazodona.
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
IT1270095B (it) Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
HUP0201629A2 (hu) Eletriptánt és ciklodextrinszármazékot tartalmazó gyógyászati komplex, ezt tartalmazó gyógyszerkészítmény, eljárás az előállítására és alkalmazása
BR0210063A (pt) Composição estável e uso da mesma
BR0012822A (pt) Formulação farmacêutica, e, forma de dosagem em tablete
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.